-
公开(公告)号:US20180141932A1
公开(公告)日:2018-05-24
申请号:US15735322
申请日:2016-06-16
IPC分类号: C07D403/14 , C07D401/14 , C07D401/04 , C07D403/12 , A61P7/02
CPC分类号: C07D403/14 , A61P7/02 , C07D401/04 , C07D401/14 , C07D403/12
摘要: The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.